Cargando…

Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro

The recent outbreak of novel coronavirus pneumonia (COVID-19) caused by a new coronavirus has posed a great threat to public health. Identifying safe and effective antivirals is of urgent demand to cure the huge number of patients. Virus-encoded proteases are considered potential drug targets. The h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Leike, Liu, Jia, Cao, Ruiyuan, Xu, Mingyue, Wu, Yan, Shang, Weijuan, Wang, Xi, Zhang, Huanyu, Jiang, Xiaming, Sun, Yuan, Hu, Hengrui, Li, Yufeng, Zou, Gang, Zhang, Min, Zhao, Lei, Li, Wei, Guo, Xiaojia, Zhuang, Xiaomei, Yang, Xing-Lou, Shi, Zheng-Li, Deng, Fei, Hu, Zhihong, Xiao, Gengfu, Wang, Manli, Zhong, Wu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481761/ https://www.ncbi.nlm.nih.gov/pubmed/32910347 http://dx.doi.org/10.1007/s12250-020-00288-1

Ejemplares similares

Antiviral effects and tissue exposure of tetrandrine against SARS‐CoV‐2 infection and COVID‐19
por: Liu, Jia, et al.
Publicado: (2023)

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
por: Liu, Jia, et al.
Publicado: (2020)

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
por: Wang, Manli, et al.
Publicado: (2020)

The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro
por: Wang, Xi, et al.
Publicado: (2020)

Comprehensive interactome analysis of the spike protein of swine acute diarrhea syndrome coronavirus
por: Wang, Qingxing, et al.
Publicado: (2021)

Quantitative Proteomic Analysis Reveals Unfolded-Protein Response Involved in Severe Fever with Thrombocytopenia Syndrome Virus Infection
por: Zhang, Lei-Ke, et al.
Publicado: (2019)

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
por: Xiong, Rui, et al.
Publicado: (2020)

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
por: Xiong, Rui, et al.
Publicado: (2020)

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
por: Xiong, Rui, et al.
Publicado: (2020)

A viral RNA-dependent RNA polymerase inhibitor VV116 broadly inhibits human coronaviruses and has synergistic potency with 3CLpro inhibitor nirmatrelvir
por: Zhang, Yumin, et al.
Publicado: (2023)

Infection of human sweat glands by SARS-CoV-2
por: Liu, Jia, et al.
Publicado: (2020)

Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
por: Su, Haixia, et al.
Publicado: (2021)

Oral remdesivir derivative VV116 is a potent inhibitor of respiratory syncytial virus with efficacy in mouse model
por: Zhang, Ruxue, et al.
Publicado: (2022)

Construction and Characterization of Severe Fever with Thrombocytopenia Syndrome Virus with a Fluorescent Reporter for Antiviral Drug Screening
por: Wang, Xiao, et al.
Publicado: (2023)

Visualizing lymphocytic choriomeningitis virus infection in cells and living mice
por: Wen, Yuxi, et al.
Publicado: (2022)

Development of horse neutralizing immunoglobulin and immunoglobulin fragments against Junín virus
por: Pan, Xiaoyan, et al.
Publicado: (2020)

Molnupiravir and Its Active Form, EIDD-1931, Show Potent Antiviral Activity against Enterovirus Infections In Vitro and In Vivo
por: Li, Yuexiang, et al.
Publicado: (2022)

In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2
por: Shang, Weijuan, et al.
Publicado: (2022)

Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir
por: Jiang, Xiangrui, et al.
Publicado: (2023)

Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses
por: Lu, Shengsheng, et al.
Publicado: (2021)

Successful Rescue of Synthetic AcMNPV with a ~17 kb Deletion in the C1 Region of the Genome
por: Guo, Yijia, et al.
Publicado: (2022)

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
por: Dai, Wenhao, et al.
Publicado: (2020)

Establishment of Human Pluripotent Stem Cell‐Derived Skin Organoids Enabled Pathophysiological Model of SARS‐CoV‐2 Infection
por: Ma, Jie, et al.
Publicado: (2021)

Azelnidipine Exhibits In Vitro and In Vivo Antiviral Effects against Flavivirus Infections by Targeting the Viral RdRp
por: Wang, Zhuang, et al.
Publicado: (2022)

A Comparative Quantitative Proteomic Analysis of HCMV-Infected Cells Highlights pUL138 as a Multifunctional Protein
por: Li, Yang, et al.
Publicado: (2020)

Discovery and Optimization of Quinoline Analogues as Novel Potent Antivirals against Enterovirus D68
por: Li, Xiaoyuan, et al.
Publicado: (2022)

Novel Tetrahydroisoquinoline-Based Heterocyclic Compounds Efficiently Inhibit SARS-CoV-2 Infection In Vitro
por: Wang, Xi, et al.
Publicado: (2023)

Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
por: Amporndanai, Kangsa, et al.
Publicado: (2021)

High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors
por: Zang, Yi, et al.
Publicado: (2022)

Activation of the STAT3 Signaling Pathway by the RNA-Dependent RNA Polymerase Protein of Arenavirus
por: Wang, Qingxing, et al.
Publicado: (2021)

Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2
por: Xie, Yuanchao, et al.
Publicado: (2021)

Immunoglobulin fragment F(ab’)(2) against RBD potently neutralizes SARS-CoV-2 in vitro
por: Pan, Xiaoyan, et al.
Publicado: (2020)

Construction and characterization of a synthesized herpes simplex virus H129-Syn-G2
por: Xiao, Han, et al.
Publicado: (2023)

Structure basis for allosteric regulation of lymphocytic choriomeningitis virus polymerase function by Z matrix protein
por: Liu, Lu, et al.
Publicado: (2023)

Norovirus Protease Structure and Antivirals Development
por: Zhao, Boyang, et al.
Publicado: (2021)

Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection
por: Wang, Shaobo, et al.
Publicado: (2017)

Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivo
por: Wang, Qianran, et al.
Publicado: (2022)

A Subcellular Quantitative Proteomic Analysis of Herpes Simplex Virus Type 1-Infected HEK 293T Cells
por: Wan, Weiwei, et al.
Publicado: (2019)

The Structure of the Porcine Deltacoronavirus Main Protease Reveals a Conserved Target for the Design of Antivirals
por: Wang, Fenghua, et al.
Publicado: (2022)

Pathological features of COVID-19-associated liver injury—a preliminary proteomics report based on clinical samples
por: Leng, Ling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_156b61qd7fu9sc5psivs0n752h